Single versus multiple arterial grafts for coronary bypass
Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: the ROMA Trial
This trial will test whether using two or more arterial grafts instead of a single arterial graft during planned coronary artery bypass surgery for people with coronary artery disease leads to fewer deaths, strokes, heart attacks, or repeat procedures.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 4300 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 59 sites (Boulder, Colorado and 58 other locations) |
| Trial ID | NCT03217006 on ClinicalTrials.gov |
What this trial studies
ROMA is a prospective, unblinded, randomized multicenter trial enrolling at least 4,300 patients undergoing primary, non-emergency isolated CABG across international centers. Participants are randomized 1:1 to receive either a single arterial graft (SAG) or multiple arterial grafts (MAG), with permuted block randomization stratified by center and type of second arterial graft. The primary endpoint is a composite of death from any cause, any stroke, post-discharge myocardial infarction, and repeat revascularization, and the trial is event-driven. Key exclusions include age over 70, left ventricular ejection fraction below 35%, emergency or repeat operations, severe end-organ dysfunction, active cancer, or lack of suitable conduit vessels.
Who should consider this trial
Good fit: Ideal candidates are adults under 70 having planned primary isolated CABG for coronary artery disease who have adequate heart function and suitable vessels for arterial grafting.
Not a fit: Patients over 70, with very low ejection fraction, emergency or repeat surgeries, severe comorbidities limiting life expectancy, or unsuitable conduit vessels are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If successful, using multiple arterial grafts could reduce long-term rates of death, stroke, heart attack, and the need for repeat coronary procedures after bypass surgery.
How similar studies have performed: Smaller randomized trials and many observational studies have demonstrated better arterial graft patency and suggest long-term survival benefits, but large definitive randomized comparisons of single versus multiple arterial grafts remain limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary isolated CABG patients with disease of the left main coronary artery and/or of the left anterior descending and the circumflex coronary system with or without disease of the right coronary artery. Exclusion Criteria: * Age \> 70 years * Single graft * Emergency operation * Evolving myocardial infarction within 48 hours of surgery * Left ventricular ejection fraction of \< 35% * Any concomitant cardiac or non-cardiac procedure * Previous cardiac surgery * Preoperative severe end-organ dysfunction (dialysis, liver failure, respiratory failure), cancer or any co-morbidity that reduce life expectancy to less than 5 years. * Inability to use the saphenous vein or to use both radial and right internal thoracic arteries * Anticipated need for coronary thrombo-endarterectomy * Planned hybrid revascularization
Where this trial is running
Boulder, Colorado and 58 other locations
- University of Colorado — Boulder, Colorado, United States (Recruiting)
- Baystate Health — Springfield, Massachusetts, United States (Recruiting)
- Nebraska Heart Hospital — Lincoln, Nebraska, United States (Recruiting)
- University of Nebraska Medical Center — Omaha, Nebraska, United States (Recruiting)
- NewYork-Presbyterian Brooklyn Methodist Hospital — Brooklyn, New York, United States (Recruiting)
- Icahn School of Medicine, Mount Sinai — New York, New York, United States (Recruiting)
- Weil Cornell Medical College Department of Cardiothoracic Surgery — New York, New York, United States (Recruiting)
- Lenox Hill Hospital (Northwell) — New York, New York, United States (Recruiting)
- NewYork-Presbyterian Queens — New York, New York, United States (Recruiting)
- Cleveland Clinic Foundation — Cleveland, Ohio, United States (Recruiting)
- Allegheny General Hospital (Cardiovascular Institute) — Pittsburgh, Pennsylvania, United States (Recruiting)
- Innsbruck (Medical University) Austria — Innsbruck, Austria (Recruiting)
- Krankenhaus Nord Vienna North Hospital — Vienna, Austria (Recruiting)
- MU Vienna Austria — Vienna, Austria (Recruiting)
- Federal University of Sao Paulo — São Paulo, Brazil (Recruiting)
- Hamilton General Hospital — Hamilton, Canada (Recruiting)
- London Health Sciences Ontario Canada — London, Canada (Recruiting)
- University Hospital of Montreal (CHUM) — Montreal, Canada (Recruiting)
- University of Ottawa Heart Institute Canada — Ottawa, Canada (Recruiting)
- Royal Victoria Hospital (McGill) — Québec, Canada (Recruiting)
- Universite Laval Quebec (CRIUCPQ) Canada — Québec, Canada (Recruiting)
- Sunnybrook Health Sciences Centre — Toronto, Canada (Recruiting)
- Toronto General Hospital — Toronto, Canada (Recruiting)
- St. Boniface General Hospital / WHRA — Winnipeg, Canada (Recruiting)
- Fuwai Hospital — Beijing, China (Recruiting)
- Jilin Heart Hospital — Changchun, China (Recruiting)
- Ruijin Hospital Shanghai Jiao Tong University School of Medicine — Shanghai, China (Recruiting)
- National Taiwan University Hospital — Taiwan, China (Recruiting)
- Teda Hospital (TICH) — Tianjin, China (Recruiting)
- University Hospital Dubrava — Zagreb, Croatia (Recruiting)
- General University Hospital, Prague — Prague, Czechia (Recruiting)
- Duisburg Heart Center — Duisburg, Germany (Recruiting)
- Essen University — Duisburg, Germany (Recruiting)
- Düsseldorf University — Düsseldorf, Germany (Recruiting)
- University Hospital Erlangen — Erlangen, Germany (Recruiting)
- Giessen Hospital — Giessen, Germany (Recruiting)
- University Medical Center of Goettingen — Göttingen, Germany (Enrolling_by_invitation)
- Jena University Hospital — Jena, Germany (Recruiting)
- Heart Center (Herzzentrum) — Leipzig, Germany (Recruiting)
- HDZ NRW Bad — Oeynhausen, Germany (Recruiting)
- Robert-Bosch-Hospital — Stuttgart, Germany (Recruiting)
- Krankenhaus der Barmherzigen Brüder Trier — Trier, Germany (Recruiting)
- Anthea Hospital — Bari, Italy (Recruiting)
- Fondazione Poliambulanza — Brescia, Italy (Recruiting)
- Maria Cecilia Hospital GVM — Cotignola, Italy (Recruiting)
- Universita' Cattolica del Sacro Cuore — Roma, Italy (Recruiting)
- European Hospital — Rome, Italy (Recruiting)
- Ospedale Le Molinette — Torino, Italy (Recruiting)
- Saitama Medical University — Saitama, Japan (Recruiting)
- MUMC Maastricht (University Medical Centre) — Maastricht, Netherlands (Recruiting)
+9 more sites — see ClinicalTrials.gov for the full list.
Study contacts
- Principal investigator: Mario Gaudino, MD — Weill Medical College of Cornell University
- Study coordinator: Mario Gaudino, MD
- Email: mfg9004@med.cornell.edu
- Phone: 212.746.1812
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.